Clinical Trial Update: Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating gemcitabine in combination with either cisplatin or carboplatin in patients with stage III or stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• Platinol (cisplatin)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Lung Cancer | Phase 3 | Status: UNKNOWN